Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase I/II trial of radiotherapy concurrent with TS-1 plus cisplatin in patients with clinically resectable type 4 or large type 3 gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1205.
Imano M, Furukawa H, Yokokawa M, Nishimura Y, Kurokawa Y, Satoh T, Sakai D, Yasuda T, Imamoto H, Tujinaka T, Shimokawa T, Shiozaki H; Osaka Gastrointestinal Cancer Chemotherapy Study Group. Imano M, et al. Jpn J Clin Oncol. 2013 Apr;43(4):431-5. doi: 10.1093/jjco/hys239. Epub 2013 Feb 26. Jpn J Clin Oncol. 2013. PMID: 23447812 Clinical Trial.
A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S-1 plus intravenous paclitaxel for serosa-positive gastric cancer.
Peng YF, Imano M, Itoh T, Satoh T, Chiba Y, Imamoto H, Tsubaki M, Nishida S, Yasuda T, Furukawa H. Peng YF, et al. Among authors: imano m. J Surg Oncol. 2015 Jun;111(8):1041-6. doi: 10.1002/jso.23928. Epub 2015 Jun 7. J Surg Oncol. 2015. PMID: 26060133 Clinical Trial.
Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601).
Matsuyama J, Terazawa T, Goto M, Kawabata R, Endo S, Imano M, Fujita S, Akamaru Y, Taniguchi H, Tatsumi M, Lee SW, Kawakami H, Kurokawa Y, Shimokawa T, Sakai D, Kato T, Fujitani K, Satoh T. Matsuyama J, et al. Among authors: imano m. Oncologist. 2022 Apr 5;27(4):251-e304. doi: 10.1093/oncolo/oyab061. Oncologist. 2022. PMID: 35380725 Free PMC article. Clinical Trial.
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
Takiuchi H, Goto M, Imamura H, Furukawa H, Imano M, Imamoto H, Kimura Y, Ishida H, Fujitani K, Narahara H, Shimokawa T. Takiuchi H, et al. Among authors: imano m. Jpn J Clin Oncol. 2008 Mar;38(3):176-81. doi: 10.1093/jjco/hyn003. Epub 2008 Feb 16. Jpn J Clin Oncol. 2008. PMID: 18281707 Clinical Trial.
176 results